PRESS RELEASE:

UK Countrywide Saliva-Based COVID-19 Testing Directive Integrates Spectrum SDNA Saliva Collection Device

Leslie Titus Bryant, Director of Marketing & Brand
January 07, 2021

Saliva-based tests rapidly expand access and testing options to combat COVID-19 in the UK

Today, Spectrum announced it has partnered with Steribottle to provide its innovative SDNA-1000 Saliva Collection Device for the COVID-19 population testing directive in the UK. Rollout of this extensive countrywide testing mandate includes every UK citizen once a week.

“Even with new vaccines, it is more important than ever before to increase the rate of testing,” said Stephen Fanning, President, and CEO of Spectrum Solutions. “Many countries are experiencing skyrocketing rates of infection. It is vital to global health and safety for individuals and governments to be aware of accurate infection rates and geographic hot spots in order to plan and execute effective healthcare strategies and initiatives. We are very proud to partner with Steribottle in this fight against COVID-19 in the UK.”

“Testing is the purposeful pursuit of knowledge and understanding. It’s not only a window providing visibility into the disease but provides a quicker path to informed decisions and treatment” said Luke Fisher, CEO of Steribottle. “The Spectrum saliva-based testing solution provides a validated system and proven process that safely mitigates unnecessary exposure.”

The Spectrum Solutions SDNA-1000 Saliva Collection Device was the first saliva-based solution to receive the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 testing. It supplants the need for the painful nasal swab process with a more accurate and pain-free saliva collection process. This easy-to-use option was engineered to eliminate user collection errors and provides a path for at-home sample self-collection that mitigates downstream exposure risks by delivering in-device viral inactivation. Offering the safest & most robust biomaterial for detecting COVID-19, the Spectrum SDNA saliva collection system provides over 10 days of post-collection stability with no degradation in sample efficacy.

PRESS RELEASE:

UK Countrywide Saliva-Based COVID-19 Testing Directive Integrates Spectrum SDNA Saliva Collection Device

Leslie Titus Bryant, Director of Marketing & Brand
January 07, 2021

Saliva-based tests rapidly expand access and testing options to combat COVID-19 in the UK

Today, Spectrum announced it has partnered with Steribottle to provide its innovative SDNA-1000 Saliva Collection Device for the COVID-19 population testing directive in the UK. Rollout of this extensive countrywide testing mandate includes every UK citizen once a week.

“Even with new vaccines, it is more important than ever before to increase the rate of testing,” said Stephen Fanning, President, and CEO of Spectrum Solutions. “Many countries are experiencing skyrocketing rates of infection. It is vital to global health and safety for individuals and governments to be aware of accurate infection rates and geographic hot spots in order to plan and execute effective healthcare strategies and initiatives. We are very proud to partner with Steribottle in this fight against COVID-19 in the UK.”

“Testing is the purposeful pursuit of knowledge and understanding. It’s not only a window providing visibility into the disease but provides a quicker path to informed decisions and treatment” said Luke Fisher, CEO of Steribottle. “The Spectrum saliva-based testing solution provides a validated system and proven process that safely mitigates unnecessary exposure.”

The Spectrum Solutions SDNA-1000 Saliva Collection Device was the first saliva-based solution to receive the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 testing. It supplants the need for the painful nasal swab process with a more accurate and pain-free saliva collection process. This easy-to-use option was engineered to eliminate user collection errors and provides a path for at-home sample self-collection that mitigates downstream exposure risks by delivering in-device viral inactivation. Offering the safest & most robust biomaterial for detecting COVID-19, the Spectrum SDNA saliva collection system provides over 10 days of post-collection stability with no degradation in sample efficacy.

Spectrum Solution SDNA Saliva Collection Device Manufacturing

Access this press release on Business Wire

Our Team, Helping your Team, get Back in the Game!

How you collect saliva makes a big diagnostic difference.
Real-world mass testing scenarios require an authorized, proven, and supported system that mitigates any risk of exposure and a company that holds a blackbelt in scalability.
Get your business back in the game.

blank

PROUD PARTNER OF MLB

™/© 2020 MLB

Our Team, Helping Your Team, Get Back in the Game!

How you collect saliva makes a big diagnostic difference. To incorporate the use of saliva into COVID-19 diagnostic testing protocols or implement actual real-world mass-testing in scalable scenarios requires an authorized, proven, validated, and supported system that actually mitigates risk of exposure and a device engineered to increase testing accuracy. Get your business back in the game.

Providing the test kits helping keep MLB™ stars on the field.

PROUD PARTNER OF MLB

blank

Get to know our #partofthesolution

About Spectrum Solutions and Spectrum DNA

Headquartered in Salt Lake City, Utah, Spectrum Solutions and its medical device and services division, Spectrum DNA, focus their concentrated industry expertise on engineering innovative end-to-end solutions for both clinical diagnostic projects and commercial product plans. A single-source provider of on-site medical device development and manufacturing, custom packaging, kitting, and direct-to-consumer fulfillment. Its biosample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Director of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Get to know our #partofthesolution

ABOUT SPECTRUM SOLUTIONS AND SPECTRUM DNA

Headquartered in Salt Lake City, Utah, Spectrum Solutions and its medical device and services division, Spectrum DNA, focus their concentrated industry expertise on engineering innovative end-to-end solutions for both clinical diagnostic projects and commercial product plans. A single-source provider of on-site medical device development and manufacturing, custom packaging, kitting, and direct-to-consumer fulfillment. Its biosample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Director of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Spectrum
in the News

Spectrum
in the News

About the Product

Innovative Engineering

Spectrum-SDNA-1000-Saliva-Collection-Proud Partner of MLB2

Spectrum Solutions has manufactured over 20 million Saliva Collection devices for distribution worldwide. Spectrum’s technically superior  SDNA-1000 saliva collection device was engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications delivering the safest and most robust biomaterial collection approach for the detection and diagnosis of disease or viral infection.

  • First saliva collection device to receive EUA authorization for COVID-19 testing
  • First saliva collection device FDA authorized for at-home sample collection
  • Only pain-free biosample collection option for COVID-19 testing
  • Engineered to reduce self-collection error
  • Delivers consistent high-quality, high-yield biosamples
  • 100% inactivation of the live virus
  • 100% bacteriostatic
  • Delivers over a 90% reduction in PPE usage compared to current swab collections for COVID-19 testing
  • Single device preserves both DNA and fragile viral RNA transcripts
  • Device stabilizes and extends biosample viability post-collection over 10 days with no degradation of sample efficacy extending shipping and transport options
  • Saliva collection system mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
Questions? Let’s Connect
Spectrum-SDNA-1000-Saliva-Collection-Proud Partner of MLB2

About the Product

Innovative Engineering

Spectrum Solutions has manufactured over 20 million Saliva Collection devices for distribution worldwide. Spectrum’s technically superior  SDNA-1000 saliva collection device was engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications delivering the safest and most robust biomaterial collection approach for the detection and diagnosis of disease or viral infection.

  • First saliva collection device to receive EUA authorization for COVID-19 testing
  • First saliva collection device FDA authorized for at-home sample collection
  • Only pain-free biosample collection option for COVID-19 testing
  • Engineered to reduce self-collection error
  • Delivers consistent high-quality, high-yield biosamples
  • 100% inactivation of the live virus
  • 100% bacteriostatic
  • Delivers over a 90% reduction in PPE usage compared to current swab collections for COVID-19 testing
  • Single device preserves both DNA and fragile viral RNA transcripts
  • Device stabilizes and extends biosample viability post-collection over 10 days with no degradation of sample efficacy extending shipping and transport options
  • Saliva collection system mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
Questions? Let’s Connect
Contact Us

Let's Connect.

#partofthesolution

Contact Us

Are you a lab? Let’s connect.

Spectrum is currently working to get SDNA-1000 saliva collection kits into the hands of private processing, university, state, and hospital labs that are working to validate the established saliva-based COVID-19 testing protocols for FDA EUA saliva testing authorization. Please contact us directly if your use case includes this goal.

#partofthesolution